Giorgio Papiani

Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience

Ugo De Giorgi, T. Demirer, H. Wandt et al. · Annals of Oncology · 2004 · 69 citations · Full text

Second-line High-dose Chemotherapy, Urology, Surgical Oncology +9

Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial

Elisa Grassi, Chiara Zingaretti, Elisabetta Petracci et al. · ESMO Open · 2023 · 34 citations · Full text

The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients.

Ugo De Giorgi, Giovanni Rosti, Giorgio Papiani et al. · PubMed · 2002 · 33 citations

A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study final results.

Stefano Tamberi, Grassi Elisa, Chiara Zingaretti et al. · Journal of Clinical Oncology · 2022 · 31 citations

Surgical Oncology, Phase Ii Study, Surgery +17

Salvage high‐dose chemotherapy in patients with germ cell tumors

Giovanni Rosti, Ugo De Giorgi, Roberto Salvioni et al. · Cancer · 2002 · 28 citations · Full text